Embecta Stock (NASDAQ:EMBC)
Previous Close
$13.48
52W Range
$9.93 - $19.79
50D Avg
$14.53
200D Avg
$13.67
Market Cap
$785.32M
Avg Vol (3M)
$354.62K
Beta
0.94
Div Yield
$0.60 (5.51%)
EMBC Company Profile
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
EMBC Performance
Peer Comparison
| Ticker | Company |
|---|---|
| MMSI | Merit Medical Systems, Inc. |
| BAX | Baxter International Inc. |
| COO | The Cooper Companies, Inc. |
| WST | West Pharmaceutical Services, Inc. |
| ATRC | AtriCure, Inc. |
| AKYA | Akoya Biosciences, Inc. |
| ATRI | Atrion Corporation |
| ALC | Alcon Inc. |
| RMD | ResMed Inc. |
| NVST | Envista Holdings Corporation |
| ANGO | AngioDynamics, Inc. |
| HAE | Haemonetics Corporation |
| ICUI | ICU Medical, Inc. |
| ATR | AptarGroup, Inc. |
| TFX | Teleflex Incorporated |